Sarepta Therapeutics (SRPT) Research & Development: 2012-2025
Historic Research & Development for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to $204.4 million.
- Sarepta Therapeutics' Research & Development rose 13.75% to $204.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 billion, marking a year-over-year increase of 59.61%. This contributed to the annual value of $804.5 million for FY2024, which is 8.30% down from last year.
- Latest data reveals that Sarepta Therapeutics reported Research & Development of $204.4 million as of Q2 2025, which was down 65.93% from $600.0 million recorded in Q1 2025.
- In the past 5 years, Sarepta Therapeutics' Research & Development registered a high of $600.0 million during Q1 2025, and its lowest value of $139.1 million during Q3 2021.
- Moreover, its 3-year median value for Research & Development was $202.4 million (2024), whereas its average is $248.6 million.
- As far as peak fluctuations go, Sarepta Therapeutics' Research & Development decreased by 26.95% in 2021, and later surged by 199.41% in 2025.
- Over the past 5 years, Sarepta Therapeutics' Research & Development (Quarterly) stood at $197.3 million in 2021, then climbed by 8.37% to $213.8 million in 2022, then dropped by 8.55% to $195.5 million in 2023, then grew by 2.27% to $200.0 million in 2024, then climbed by 13.75% to $204.4 million in 2025.
- Its Research & Development stands at $204.4 million for Q2 2025, versus $600.0 million for Q1 2025 and $200.0 million for Q4 2024.